Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of PLENVU in Healthy Subjects
NCT03437265Phase 1Completed
- Sponsor
- Norgine
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of polyethylene glycol + electrolytes + ascorbic acid in Gastrointestinal cleansing, sponsored by Norgine. Primary endpoints: Time to Maximum Plasma Concentration, Half-Life and 4 more. Started Sep 2020; status: completed.
02
Drugs
polyethylene glycol + electrolytes + ascorbic acid
03
Conditions
Gastrointestinal cleansing
Beyond the preview
Go deeper on NCT03437265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03437265.